Santa Rosa Memorial Hospital Regional CCOP

圣罗莎纪念医院CCOP(SRMH CCOP)是一个核心集约化发展的结果 在一个相对孤立的五县地区为80%的癌症患者提供服务的肿瘤学家小组 加利福尼亚州北部。组成红木地区医疗中心的16名内科和放射肿瘤学家 该集团每年接待超过2800名新患者。两个新的附属网站加入了SRMH CCOP在 上个供资期间，增加了五名肿瘤学家，扩大了地理集水区 从而确保有足够的患者群体进行临床试验。SRMH CCOP提供 需要提供支持，以增加获得五个国家最新癌症治疗和控制研究方案的机会 它所服务的县。患者群体包括相当数量的未得到充分服务的农村、族裔和 CCOP为其提供最先进技术的社会经济弱势个人 治疗。我们的计划系统地汇集了必要的资源：训练有素的肿瘤学家， 一名经验丰富的专家数据管理人员，合作小组临床试验，高质量控制 标准、医院资源承诺和非肿瘤学专家的参与。临床部 研究团队开发了一种有效的病例查找方法，以确保实现CCOP 目标。特别值得注意的是，该计划在癌症控制收益方面取得了非常成功的记录，导致 168人登记参加PCPT试验，40名患者登记参加STAR试验。作为指定的 选择地点，我们今年已经登记了28名患者参加这项研究。CCOP计划注册至少 从40名患者中挑选出10名患者作为今年的明星。

The Santa Rosa Memorial Hospital CCOP(SRMH CCOP) is the result of intensive development by a core group of oncologists who serve 80% of the`cancer patients in a relatively isolated five county area in Northern California. The sixteen medical and radiation oncologists who form the Redwood Regional Medical Group see over 2800 new patients per year. Two new affiliate sites have joined the SRMH CCOP during the last funding period, bringing an additional five oncologists and expanding the geographic catchment area thus ensuring an adequate patient population for clinical trials accrual. The SRMH CCOP provides the support needed to increase access to the latest cancer treatment and control research protocols in the five counties it serves. The patient population includes a significant number of underserved rural, ethnic and socio-economically disadvantaged individuals for whom the CCOP provides access to state-of-the-art treatment. Our program has systematically assembled the necessary resources: highly trained oncologists, an expert data management staff experienced with cooperative group clinical trials, high quality control standards, hospital resource commitments and involvement of non-oncology specialists. The clinical research team has developed an effective case-finding approach which ensures achievement of CCOP goals. Of particular note is the program's highly successful track record in cancer control accrual resulting in 168 persons being registered to the PCPT trial and 40 patients registered to the STAR trial. As a designated SELECT site, we have registered 28 patients to the study this year. The CCOP plans to register a minimum of 40 patients to SELECT and 10 patients to STAR this year.